Test Price
2,800 AED✅ Home Collection Available
TTN Gene Limb‑Girdle Muscular Dystrophy, Autosomal Recessive Type 2J Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Next‑Generation Sequencing (NGS) with full bioinformatics validation.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Complimentary telephonic post‑test clinical guidance with a licensed genetic counsellor to interpret your results.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The TTN gene test identifies pathogenic variants causing limb‑girdle muscular dystrophy type 2J (LGMD2J), an autosomal recessive disorder characterised by progressive proximal muscle weakness. Using Next‑Generation Sequencing (NGS) of the entire titin gene, this assay delivers definitive molecular diagnosis and guides personalised management, family planning, and research.
| Feature | Our Test (NGS) | Single‑Gene Sanger Sequencing |
|---|---|---|
| Methodology | Next‑Generation Sequencing (full TTN coverage) | Targeted exon‑by‑exon Sanger |
| Diagnostic Yield | >95% for LGMD2J | ~60% (misses deep intronic/copy variants) |
| Turnaround Time | 3–4 Weeks | 8–12 Weeks (full TTN impractical) |
| Clinical Reporting | ACMG‑classified variants with in‑silico evidence | Limited bioinformatics support |
Physician Insight & Safety Protocols
Insight from Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403
“Molecular confirmation of LGMD2J through TTN gene sequencing provides definitive diagnostic clarity, enabling targeted surveillance for cardiac and respiratory complications. However, genetic findings must be interpreted alongside clinical examination, serum creatine kinase levels, and family pedigree analysis. A negative result does not exclude all forms of limb‑girdle muscular dystrophy, as other genetic loci may be involved.”
Advisory – Medication Continuity
Patients under active pharmacological therapy for neuromuscular or cardiac conditions must maintain their prescribed regimen unless explicitly instructed to modify by the treating specialist. Genetic test results supply diagnostic and prognostic information but do not supersede clinical judgement or ongoing therapeutic monitoring.
Exclusion Criteria & Emergency Red Flags
- Active febrile illness or systemic infection – postpone collection until resolved.
- Severe coagulopathy or ongoing anticoagulant therapy that cannot be safely paused under medical supervision.
- Inability to provide informed consent; for minors, documented consent from a legal guardian with pre‑test genetic counselling is required per Federal Decree‑Law No. 4 of 2016 on Medical Liability.
- If you experience sudden respiratory distress, severe cardiac palpitations, or rhabdomyolysis‑like symptoms, seek emergency medical attention immediately – these may indicate a metabolic crisis unrelated to the test.
Patient FAQ & Clinical Guidance
1. What exactly does the TTN gene test diagnose, and who should consider it?
This test identifies disease‑causing mutations in the titin gene, confirming limb‑girdle muscular dystrophy type 2J, a progressive muscle‑wasting condition. Individuals presenting with unexplained proximal muscle weakness, elevated creatine kinase levels, or a documented family history of LGMD should pursue this assay following formal genetic counselling.
2. What is the turnaround time and how is the sample collected?
The turnaround time is 3 to 4 weeks from sample receipt. Collection involves a standard peripheral whole blood draw performed by a certified phlebotomist. Home collection via VIP Mobile Phlebotomy with temperature‑controlled cold‑chain logistics is available daily from 8 AM to 11 PM across Dubai and select UAE locations.
3. Will my health insurance in the UAE cover the 2800 AED cost?
Coverage depends on your specific insurance plan. DNA Labs UAE offers direct billing verification and pre‑approval assistance via WhatsApp at +971 54 548 8731. Our team will confirm eligibility under DHA‑recognised diagnostic codes and guide you through the reimbursement process.
4. Are post‑test genetic counselling services included with this test?
Yes, a complimentary telephonic session with a licensed genetic counsellor is provided to explain your results, discuss inheritance patterns, and address family planning implications. This service aligns with UAE regulations requiring pre‑ and post‑test counselling for diagnostic genetic testing.
UAE Regulatory & Data Privacy Adherence
Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL): All genetic data generated by this assay is encrypted, stored on‑shore within UAE data centres, and handled in strict compliance with patient privacy regulations. DNA Labs UAE guarantees the right to data deletion upon formal request.
Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields: This laboratory operates under a DHA‑approved facility (License 1143) and adheres to all digital health data security standards for the transmission, storage, and processing of electronic medical records.
Federal Decree‑Law No. 4 of 2016 on Medical Liability: Patient safety and informed consent protocols follow this framework, ensuring that all clinical procedures, including genetic testing and specimen collection, meet the highest medical liability standards in the UAE.
ISO 9001:2015 Certification: DNA Labs UAE is certified under quality management standard ISO 9001:2015, ensuring consistent diagnostic excellence and continuous process improvement in genetic diagnostics.
Clinical & Logistical Metadata
| Test Name | TTN Gene Limb‑Girdle Muscular Dystrophy, Autosomal Recessive Type 2J Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks (21–28 business days) |
| Sample Type / Matrix | Whole Blood (EDTA) – Peripheral Venipuncture |
| Methodology Used | Next‑Generation Sequencing (NGS) – Full TTN Gene Coverage with Bioinformatics Variant Classification per ACMG Guidelines |
| ICD-10-CM Code | G71.0 (Muscular dystrophy), Z13.79 (Screening for genetic anomalies), Z14.8 (Genetic carrier status) |
| LOINC Code | 81308-4 (Titin gene full mutation analysis in Blood or Tissue by Molecular genetics method) |
| DHA Facility License & Laboratory Address | DHA License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians